Outset Medical, Inc. reaffirmed earnings guidance for the year 2024. The company reaffirmed its previously provided guidance for 2024 including revenue of $145 million to $153 million, growing 12% to 18% over 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.87 USD | -3.01% | +7.20% | -28.47% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.47% | 206M | |
+10.03% | 223B | |
+13.59% | 194B | |
+20.01% | 141B | |
+30.83% | 109B | |
+2.05% | 64.85B | |
+15.38% | 52.7B | |
+3.96% | 51.77B | |
+8.37% | 44.12B | |
+3.27% | 36.21B |
- Stock Market
- Equities
- OM Stock
- News Outset Medical, Inc.
- Outset Medical, Inc. Reaffirms Earnings Guidance for the Year 2024